drugset

drugset / Trial / NCT02816710

Conbercept Injection in Treatment of Severe Proliferative Diabetic Retinopathy

NCT02816710 ↗

Phase 4 Completed 112 enrolled Ruijin Hospital

RandomizedParallel-groupOpen-labelTreatment

Summary

To evaluate efficacy of different intravitreal Conbercept injection therapy in the treatment of severe proliferative diabetic retinopathy.

Timeline

Start: 2016-07
Primary completion: 2017-09
Completion: 2017-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Conbercept	Protein / enzyme biologic	—	Other

Indications